What's Happening?
The New York Mets are set to lose pitcher Frankie Montas for the entire 2026 season due to a torn UCL that requires surgery. According to reports, Montas will undergo Tommy John surgery, a procedure that typically sidelines players for an extended period. Montas, who has a $17 million player option for the 2026 season, is expected to exercise this option, impacting the Mets' financial and strategic planning for the upcoming season.
Why It's Important?
Montas' absence is a significant blow to the Mets' pitching rotation, potentially affecting their competitiveness in the 2026 season. The financial implications of his $17 million player option add to the team's challenges, as they must navigate salary cap considerations while seeking replacements or adjustments to their roster. This development could influence the Mets' offseason strategies, including potential trades or acquisitions to fill the gap left by Montas.
AD
What's Next?
The Mets will need to explore options to strengthen their pitching staff in Montas' absence. This may involve promoting talent from within their farm system or pursuing trades and free-agent signings. The team's management will likely focus on maintaining a competitive edge in the league, despite the setback. Additionally, Montas' recovery and rehabilitation process will be closely monitored to assess his future contributions to the team.
